Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05810636

Hyperactivity Assessment in Children With Attention-deficit Hyperactivity Disorder

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity. Clinical diagnosis of this disorder depends of history taking, parent report, and questionnaire. Attention test such as continuous performance test can provide quantitative measurement on attention deficits; however, there is a lack of objective tool to quantify the activity level. This study aims to assess activity level in children with ADHD. We plan to recruit 50 children with ADHD and 50 neurotypical children. The activity level measured by wearable device will be compared between ADHD and neurotypical children. The correlation between behavior rating on questionnaire and quantitative data measured by wearable device will be analyzed.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Attention Deficit Disorder With Hyperactivity Attention Deficit and Disruptive Behavior Disorders Mental Disorders Neurodevelopmental Disorders

Age range

6 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, 10048, Taiwan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

ADHD group:

Inclusion criteria

  • DSM-5 Attention-deficit hyperactivity disorder
  • 7~18 years old
  • Willing to carry smartwatch and smartphone most of the time during one-month study period

Exclusion criteria

  • Comorbid with major psychiatric disorders (i.e., schizophrenia, bipolar disorder) or neurodevelopmental disorders (i.e., intellectual disability, autism spectrum disorder)
  • Unable to use smartwatch and smartphone

Neurotypical group:

Inclusion criteria

  • 7~18 years old without a diagnosis of Attention-deficit hyperactivity disorder
  • Willing to carry smartwatch and smartphone most of the time during one-month study period

Exclusion criteria

  • Have a diagnosis of major psychiatric disorders (i.e., schizophrenia, bipolar disorder) or neurodevelopmental disorders (i.e., intellectual disability, autism spectrum disorder)
  • Unable to use smartwatch and smartphone

Treatment and study plan

Garmin Vivosmart wearable device

Device

Wearing smartwatches to collect data

Primary outcomes

  1. Acceleration

    Time frame: 24 hours for 30 days

    Arm Acceleration

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Apr 12, 2023
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.